Treatment Of Post-Operative Surgical Pain
Patent No. EP4181943 (titled "Treatment Of Post-Operative Surgical Pain") was filed by Ipsen Biopharm on Jul 16, 2021. The application was issued on Dec 17, 2025.
Patent Summary
Botulinum toxin A given 10–20 days before surgery to stop post-op pain and anxiety by blocking nerve signals before incision. The toxin travels from the injection site to the spinal cord, cutting off pain signals before they reach the brain. This approach avoids opioid addiction and prevents chronic pain that often follows poor acute management.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
EP4181943
- Application Number
- EP21746543A
- Filing Date
- Jul 16, 2021
- Status
- Granted And Under Opposition
- Nov 14, 2025
- Publication Date
- Dec 17, 2025
- External Links
- Slate, Register , Google Patents